Suppr超能文献

检测胰腺癌患者 ATM、BRCA1 和 BRCA2 启动子甲基化。

Examination of ATM, BRCA1, and BRCA2 promoter methylation in patients with pancreatic cancer.

机构信息

Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

Pancreatology. 2021 Aug;21(5):938-941. doi: 10.1016/j.pan.2021.03.015. Epub 2021 Mar 28.

Abstract

BACKGROUND

Pancreatic cancer is a lethal disease with a poor 5-year survival rate. Pathogenic germline variants in the coding regions of ATM, BRCA1, and BRCA2 are found in up to 4.8% of pancreatic cancer patients. Germline promoter methylation and gene silencing arising from a germline variant or through other mechanisms have been described as a cause of tumor suppressor gene inactivation.

METHODS

We measured the level of promoter methylation of the ATM, BRCA1, and BRCA2 genes in peripheral blood lymphocytes from 655 patients with pancreatic cancer using real-time PCR.

RESULTS

No evidence of germline promoter methylation of any of these genes was found. Promoter methylation levels were minimal with no patient having promoter methylation greater than 3.4%, 3.3%, and 7.6% for ATM, BRCA1 and BRCA2, respectively, well below levels found in patients who have inherited promoter methylation (∼50%).

CONCLUSIONS

We found no evidence of germline promoter methylation for the pancreatic susceptibility genes ATM, BRCA1 and BRCA2 in patients with pancreatic cancer. This study reveals that constitutive germline methylation of promoter CpG islands is rare in pancreatic cancer.

摘要

背景

胰腺癌是一种致命疾病,5 年生存率很低。多达 4.8%的胰腺癌患者存在 ATM、BRCA1 和 BRCA2 编码区的致病性种系变异。种系变异或通过其他机制引起的启动子甲基化和基因沉默被认为是肿瘤抑制基因失活的原因。

方法

我们使用实时 PCR 测量了 655 例胰腺癌患者外周血淋巴细胞中 ATM、BRCA1 和 BRCA2 基因的启动子甲基化水平。

结果

未发现这些基因的种系启动子甲基化证据。启动子甲基化水平很低,没有患者的启动子甲基化水平大于 ATM、BRCA1 和 BRCA2 的 3.4%、3.3%和 7.6%,远低于遗传性启动子甲基化患者的水平(约 50%)。

结论

我们在胰腺癌患者中未发现 ATM、BRCA1 和 BRCA2 易感性基因的种系启动子甲基化证据。本研究表明,胰腺癌中组成型种系 CpG 岛甲基化很少见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df3a/8355034/fca61d5e5d3c/nihms-1691691-f0001.jpg

相似文献

本文引用的文献

1
The American Cancer Society's Facts & Figures: 2020 Edition.美国癌症协会《2020年事实与数据》版
J Adv Pract Oncol. 2020 Mar;11(2):135-136. doi: 10.6004/jadpro.2020.11.2.1. Epub 2020 Mar 1.
3
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
4
Maintenance Olaparib for Germline -Mutated Metastatic Pancreatic Cancer.维持奥拉帕利治疗种系突变转移性胰腺癌。
N Engl J Med. 2019 Jul 25;381(4):317-327. doi: 10.1056/NEJMoa1903387. Epub 2019 Jun 2.
5
Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study.胰腺癌遗传力和遗传结构分析:PanC4 研究。
Cancer Epidemiol Biomarkers Prev. 2019 Jul;28(7):1238-1245. doi: 10.1158/1055-9965.EPI-18-1235. Epub 2019 Apr 23.
9
Inherited pancreatic cancer.遗传性胰腺癌。
Chin Clin Oncol. 2017 Dec;6(6):58. doi: 10.21037/cco.2017.12.04.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验